Biotech Patenting: Council Of Ministers Close To Common Position
After a lengthy negotiation, European Union countries' ambassadors tothe EU have recommended that national ministers adopt the latest draft of the biotechnology patenting directive at their meeting on November 27.
The latest text takes up all 66 amendments voted by the European Parliament in July this year. Should the text be agreed as it stands, it becomes very difficult indeed for the Parliament to amend it again, having seen all its first reading amendments incorporated.
"Green" Opponents In UK, Belgium, Netherlands and Denmark The negotiations on the directive have been conducted against a background of extreme uncertainty, due to opposition from Green opponents in the UK, Austria, Belgium, The Netherlands and Denmark.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze